Lowell Blake & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Lowell Blake & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.92M	Buy	5,770 +3,335	+137%	+$1.78M	0.82%	29
2023 Q2	$1.27M	Buy	2,435 +1,185	+95%	+$639K	0.37%	34
2023 Q1	$720K	Buy	1,250 +713	+133%	+$402K	0.22%	40
2022 Q4	$296K	Hold	537	–	–	0.1%	49
2022 Q3	$272K	Sell	537 -1	-0.2%	-$560	0.11%	47
2022 Q2	$292K	Sell	538 -187	-26%	-$103K	0.11%	47
2022 Q1	$428K	Hold	725	–	–	0.16%	44
2021 Q4	$484K	Hold	725	–	–	0.19%	42
2021 Q3	$414K	Hold	725	–	–	0.19%	44
2021 Q2	$366K	Hold	725	–	–	0.17%	46
2021 Q1	$331K	Hold	725	–	–	0.17%	43
2020 Q4	$338K	Buy	725 +25	+4%	+$11.7K	0.25%	36
2020 Q3	$309K	Hold	700	–	–	0.25%	42
2020 Q2	$254K	Buy	+700	New	+$235K	0.24%	45
2020 Q1	–	Sell	-700	Closed	-$227K	–	58
2019 Q4	$227K	Buy	+700	New	+$212K	0.25%	55

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lowell Blake & Associates's TMO Position: Q3 2023 in Review

Lowell Blake & Associates increased its Thermo Fisher Scientific (TMO) stake by 137% in Q3 2023, buying an estimated $1.78M and bringing the position to 5,770 shares worth $2.92M. The position accounts for 0.82% of the portfolio, ranked #29.

Lowell Blake & Associates first reported a position in TMO in Q4 2019 and has held it in 15 quarters since. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Lowell Blake & Associates held 5,770 shares of Thermo Fisher Scientific worth $2.92M as of Q3 2023.
Lowell Blake & Associates bought 3,335 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.78M.
Thermo Fisher Scientific made up 0.82% of Lowell Blake & Associates's portfolio in Q3 2023, its #29 holding.
Lowell Blake & Associates first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 15 quarters since.
2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Lowell Blake & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.